Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Form 8.3 - Advanced Medical Solutions Group plc - Octopus Investments
-
HNI Corporation Reports Third Quarter 2026 Results
-
ARCHIMED Life Science Tools & Services Completes Acquisition of Standard BioTools’ Microfluidics Business, Now Biomark Scientific
-
Palvella Therapeutics to Participate in the Stifel 2026 Healthcare Conference
-
IMS Legal Strategies Continues Life Care Planning Expansion To Support Its Growth Strategy with Addition of Medical & Life Care Consulting Services
-
IMS Legal Strategies Expands to Include Nurse Case Management To Support Its Growth Strategy with Addition of Medical & Life Care Consulting Services
-
Ascentage Pharma to Participate in Two Upcoming Investor Conferences in London
-
TurboGen Completes Assembly of First TR2000 20kW Combined Heat and Power System for Use in Defense and Civilian Markets
-
Helus Pharma to Participate in the Guggenheim Healthcare Innovation Conference
-
One Bullion Reports Significant Historical Gold Results and Advances Exploration at Vumba
-
Foremost Announces Formation of GR and Blackwing Joint Ventures and Issuance of Warrants to Denison at a Significant Premium
-
BridgeBio to Present New Acoramidis Data on Heart Failure Events in ATTR-CM at the American Heart Association Scientific Sessions 2026
-
Creative Realities, Inc. Announces Third Quarter 2026 Earnings Release Date and Conference Call Information
-
IMS Legal Strategies Expands to Include Nurse Case Management To Support Its Growth Strategy with Addition of Medical & Life Care Consulting Services
-
IMS Legal Strategies Continues Life Care Planning Expansion To Support Its Growth Strategy with Addition of Medical & Life Care Consulting Services
-
Intermap Appoints Terry Ryan to Board of Directors
-
Habit Drops a $2 / $4 / $6 MyHabit Exclusive Value Menu
-
Beta Bionics Announces Participation at Upcoming Investor Conferences
-
Winshear Starts Drill Testing Strong EM Target at the Portsoy Nickel-Copper-Cobalt Project, Northeast Scotland
-
IBN Introduces North America Media Network: Expanding News Distribution Across the U.S. and Canada
-
Decoy Therapeutics Provides Third Quarter 2026 Business Update
-
Hydrofarm Eliminates $109 Million in Debt, Becoming Debt-Free
-
Kailera Therapeutics to Participate in November Investor Conferences
-
Nexera Technologies: Subsidiary Fort Technology Announces Receipt of Approval for a Voluntary Delisting of its Common Shares From the TSX Venture Exchange
-
Renee Mustered Announces a New Milestone in Vilomah’s Development as a Grief-Support Platform
-
Xometry Reports Record Third Quarter 2026 Results
-
Nearly one-third of the world’s largest companies have not publicly acknowledged any AI risks
-
Labrador Gold Announces Management Additions
-
Dr. Oetker Launches Fifth Year of Giuseppe Practice with a Pro, Welcomes P.K. Subban as the Program’s New Ambassador
-
UPDATE: Accelerated Wealth Partners Enters into Definitive Agreement to Partner with $5 Billion Wealth Manager Pallas Capital Advisors
-
HR Tech 2026: 43 Percent of Attending HR Professionals Plan to Buy HR Technology Within a Year
-
First Watch Restaurant Group, Inc. Reports Q3 2026 Financial Results
-
NexGold Intersects 4.16 g/t Gold over 7.0 Metres, 2.84 g/t Gold over 7.0 Metres and 1.94 g/t Gold over 9.0 Metres in RC Infill Drill Program at the Goldboro Gold Project, Nova Scotia
-
Jade Biosciences to Participate in Upcoming Conferences
-
OutSolve Named a 2026 Inc. Power Partner for Business Products and Services
-
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Cartesian Therapeutics Announces New Employment Inducement Grant
-
QUANTRO Therapeutics secures key Austrian research grant to build its AI-powered drug discovery platform
-
The great housing adaptation - Canadians are adapting, not abandoning, homeownership goals
-
Relmada Therapeutics to Report Third Quarter 2026 Financial Results on Thursday, November 12, 2026
-
Cardiff Oncology to Participate in the UBS Global Biopharma Conference
-
MTY Announces CEO Leadership Transition
-
Seres Therapeutics Announces Publication of SER-155 Phase 1b Results in Nature Medicine Showing Reduced Bloodstream Infections in Allogeneic Hematopoietic Cell Transplantation Recipients
-
Aurora Mobile's EngageLab Partners with SKYWORTH Solar to Support Global Channel Operations and Project Delivery with AppPush
-
North Sky Metals Completes Maiden Drill Program at the Natlan Project, British Columbia; Assays Pending
-
Opus Genetics to Present at the Guggenheim Annual Healthcare Innovation Conference
-
Madrigal Pharmaceuticals Reports Third-Quarter 2026 Financial Results and Provides Corporate Updates
-
InflaRx Highlights Izicopan Development Path and Commercial Opportunity in ANCA-Associated Vasculitis at Capital Markets Day
-
Parabilis Medicines to Participate in Upcoming November Investor Conferences
-
Luckin Coffee Announces Third Quarter 2026 Financial Results
